Explore the latest public health research and insights about drugs.
For nearly 20 years, the Medicare program has been at the mercy of the private sector. But the Inflation Reduction Act has the potential to save Americans billions of dollars in drug costs.
Looking for prominent public health experts in the field of drugs? They’re here at the Bloomberg School of Public Health.
Joshua Sharfstein, MD, works to develop and promote public health strategies, healthcare payment approaches, and regulatory policies that advance health and equity.
G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.
Gerard Anderson, PhD, works with policymakers to control health care spending.
Aditi Sen, PhD, MA, is a health economist working to design and implement payment and delivery systems that improve quality of and access to care for all Americans.
